Godrej Industries approves re-appointment of Vishal Sharma and fundraising plans
Godrej Industries · Diversified
Key highlights
- Re-appointment of Mr. Vishal Sharma as Whole Time Director and Executive Director & CEO (Chemicals) from April 1, 2027, to March 31, 2030, subject to shareholder approval
- Approval to raise up to ₹1,500 crore via unsecured NCDs/Bonds/private placement, subject to shareholder approval
- Approval for further investment of up to ₹1,000 crore in wholly owned subsidiary Godrej Investment Limited, subject to shareholder approval
Why it's rated notable: amount is ₹500 crore or more
Original filing
Announcement under Regulation 30 (LODR)-Change in Management
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other fundraise / allotment filings this fortnight
- Supreme Engineering allots 14,50,00,000 warrants at ₹2.60 on preferential basis
- Bajaj Finance Limited allots 5.74 crore warrants to Bajaj Finserv on 10 Nov 2026
- Bajaj Finance approves preferential issue of 5.74 crore warrants to Bajaj Finserv
- Chaman Metallics Limited announces H1 FY27 financial results and proposed Rights Issue
- Harmony Capital Services receives BSE approval for preferential issue of shares
- Kuber Udyog: open offer corrigendum, allotments of shares and warrants at ₹23.10
Potential multibaggers · Q2 FY27
This quarter's potential multibaggers
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.